Total serum RANKL concentration and RANKL/OPG ratio were significantly elevated in IBD patients, particularly those with CD (Figure 6 and Figure 7, p = 0.002 and p = 0.005, respectively). This evidence concerns the gene TNFRSF11B and inflammatory bowel disease.